Loading…

iVascular S.L.U. and Braile Biomedica entered into a joint-venture agreement to develop innovative structural heart solutions, focusing on percutaneous aortic and mitral heart valves. The new entity will be based in Barcelona, Spain.
“The combination of established Braile high quality heart valve technology with iVascular unique know how and vertical integration, is an ideal configuration for bringing innovative solutions to the structural heart market.”ivascular.global
Summarized from public sources; check the original articles before acting on it.